The need to address or circumvent this limitation is obvious from the increasing number of reports of low to moderate risk genetic variants contributing to breast cancer [29-33] and recent evidence that rare variants of known breast cancer genes (including BRCA1 and BRCA2) act additively or multiplicatively to significantly increase cancer risk at the individual level [34]. The gene discussed is BRCA1; the disease is breast carcinoma.